Despite a tidal surge that overtook its manufacturing facility, Meco intends to remain a strong total solutions provider for the biopharmaceutical industry and now boasts two facilities in Southeast Louisiana and Houston.
More than 80 per cent of the company's employees suffered substantial damage to their homes during the storm, still product development in the firm has carried on at an unabated pace.
The company recently introduced its M-series for the production, storage and distribution of USP-purified and WFI-grade water into a single integrated module.
"The M-series offers consolidated controls and convenience and is backed by our Mastersupport and Meco Water System Guarantee," said Meco president George Gsell.
"Meco M-series can save companies hundreds of thousands of dollars by delivering the training, technology and expertise that makes this product a truly turnkey solution to their water purification needs."
The M-series system uses less water and less space than other water systems, cutting water usage by as much as 25 per cent and delivering pharmaceutical-grade water with a significantly smaller system footprint.
It includes a patented integral sanitation feature, producing water that, according to Meco, surpasses the most stringent pharmaceutical-industry requirements.
What is more, in its third patent in the past five years, Meco has registered a distillation and sanitisation technology for producing USP-purified water.
This new water purification method manufactures pharmaceutical-grade water through distillation in a mechanical vapor compression unit that sanitises the equipment using low-pressure steam generated by the process.
"Meco is setting the standard for Purified Water and Pure Steam critical systems in the biopharmaceutical industry," said Gsell.
"This unprecedented step in biopharmaceutical water purification is further evidence of the expertise and highly advanced designs that have made Meco a leader in providing high quality water solutions for our clients."
Treatment steps include a backwashable, chlorine-tolerant microfilter or ultrafilter, followed by a water-softening step and de-chlorination step.
Ammonia is removed from the de-chlorinated water prior to subjecting the water to distillation in the mechanical vapor compression unit.
The improved water treatment system does not require reverse osmosis to produce Pharmacopoeia-purified water quality.